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Abstract: While polymer microneedles may easily be fabricated by casting a solution in a 
mold, either centrifugation or vacuumizing is needed to pull the viscous polymer solution into 
the microholes of the mold. We report a novel process to fabricate polymer microneedles with 
a one-sided vacuum using a ceramic mold that is breathable but water impermeable. A polymer 
solution containing polyvinyl alcohol and polysaccharide was cast in a ceramic mold and 
then pulled into the microholes by a vacuum applied to the opposite side of the mold. After 
cross-linking and solidification through freeze-thawing, the microneedle patch was detached 
from the mold and transferred with a specially designed instrument for the drying process, 
during which the patch shrank evenly to form an array of regular and uniform needles without 
deformation. Moreover, the shrinkage of the patches helped to reduce the needles’ size to ease 
microfabrication of the male mold. The dried microneedle patches were finally punched to 
the desired sizes to achieve various properties, including sufficient strength to penetrate skin, 
microneedles-absorbed water-swelling ratios, and drug-release kinetics. The results showed 
that the microneedles were strong enough to penetrate pigskin and that their performance was 
satisfactory in terms of swelling and drug release.
Keywords: polymer microneedles, ceramic mold, polyvinyl alcohol, swelling
Introduction
Microneedle technology has been developing as a drug-delivery system for more 
than a decade.1 The principal advantage of microneedles is that they can provide a 
minimally invasive means of transporting molecules into the skin.2 This is particularly 
true for protein and peptide drugs, which are mostly administered by frequent injections 
due to their large molecular weight, short in vivo life, and poor tissue membrane 
permeability.3 Frequent injections are commonly used for many protein/peptide drugs 
in the treatment of chronic conditions, eg, insulin for diabetes and calcitonin for 
osteoporosis. Guided by this goal, practitioners have employed a number of specific 
strategies to use microneedles for transdermal delivery. Based on their structures 
and materials, microneedles may be classified into three categories: inorganic solid 
microneedles,4,5 hollow microneedles,6,7 and polymer microneedles.8–10 Among these 
microneedle technologies, polymer microneedles are the most feasible due to their 
uncomplicated fabrication and low cost.
Molding has been commonly used in the fabrication of polymer microneedles.8,11,12 
In brief, the drug-loaded polymer solution is pulled into microholes after casting on the 
surface of the female microneedle mold, which is made of polydimethylsiloxane.8,11–13 
Methods reported in achieving this process include centrifugation8 and vacuumizing,11,12 
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in which the bubbles in the microholes are exhausted to the 
surface of the polymer solution. However, centrifugation is 
restricted in its use due to size limitations of centrifuge rotors. 
In addition, polymer solutions used with a vacuum must 
be prepared in a low concentration or viscosity, which is a 
complicated operation. Furthermore, the low consistency of 
the polymer can make the drying process challenging, since 
deformation occurs when water is removed. Sullivan11 pre-
pared microneedles with polymerization of liquid monomer, 
which showed satisfactory fluidity. However, the introduc-
tion of a chemical initiator may damage the protein drug’s 
activity as well as human skin in treatment.
In this study, we report a novel fabrication method of 
polymer microneedles to solve the problems mentioned 
above. Chinese purple sand was used to prepare the female 
mold. Purple sand is a material that is commonly used in 
the production of traditional Chinese ceramic teapots and 
cups,14 and it has no adverse effects on the human body.15 
Besides its durability and characteristic hardness preventing 
deformation, the main reason for choosing purple sand as a 
female mold was its property of being breathable but water 
impermeable. The breathable property was used to pull the 
polymer solution into the microholes, with a vacuum under 
the female mold (Figure 1) to simplify the operation. The 
water impermeability was useful in preventing drug loss 
due to siphonage. With this female mold, we fabricated a 
microneedle patch using polyvinyl alcohol (PVA) solution, 
which was cross-linked and solidified by freeze-thawing to 
form microneedles. Free drying and fixed drying were used 
as two separate steps in the drying process. Free drying was 
used to adjust the intervals of the microneedles because of 
shrinking. This drying step solved the limitation of the size of 
the microholes in the mold, thus reducing the difficulty and 
cost of mold preparation. Fixed drying was used to remove 
the remaining water and make the needles sufficiently hard. 
Integrative and partial drug-loaded microneedles were fab-
ricated to ensure sustained release and fast-acting treatment, 
respectively (Figure 1).
Materials and methods
Materials
The purple sand was provided by Ceramics Research 
Institute (Yixing, China). The PVA, dextran, and sodium 
carboxymethylcellulose (CMC) used in this study were 
purchased from Sigma Corporation (St Louis, MO).
Molding
Thousands of hexagonal steel sticks were finished into 
needles with a tip angle of α and then cut into the same length 
(5 cm), as shown in Figure 2A. All needles were gathered and 
fixed in a steel bucket, followed by the nesting of a Teflon 
board. The board was made with an array of microholes to 
meet the needles’ tips. After fixing the board with screws, the 
core of the male mold was prepared (Figure 2B). According 
to the core’s size, a stainless shell and lid were prepared to 
form space for the purple sand. The shell was a combination 
of two semicolumns (Figure 2C), which could be separated 
when detaching the purple-sand mold.
Purple-sand mud was firstly prepared by blending dry 
purple sand and water in a ratio of 50:9. Forty-five grams of 
mud (with a particle size of 1–5 µm) was smoothly dispersed 
into the male mold, followed by a pressing of the lid at 400 
psi with a hand-operated hydraulic press (YS20; Qirui Tech, 
Suzhou, China). After separation from the shell, the purple-
sand mold was placed on an experiment table for 12 hours to 
air-dry. This adobe was transferred into an electric furnace 
Female mold
made of purple sand
Freeze-thawing
Detaching
For sustained release
For fast acting
Blank
membrane Freeze-thawing
Detaching
Drying
Drying
Figure 1 Full view of fabrication process of polymer microneedle patch. The patch was fabricated by casting polymer solution in mold, cross-linking to form needles through 
freeze-thawing, detaching, and drying.
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(SX-5-12; Botai Experimental Equipments, Shanghai, China) 
to remove the remaining water at a temperature of 300°C for 
2 hours. The final female mold product was obtained after 
calcinating it at a temperature of 920°C–1040°C for 3 hours 
and cooling it to room temperature (Figure 2D).
Preparation of the microneedle patches
Two types of microneedles were fabricated to meet different 
therapeutic needs. For sustained release, the microneedle was 
prepared as a whole patch, with the drug loaded both into the 
needles and a backing layer. For fast release, the drug was 
simply loaded into the needles.
The polymer solution used to fabricate the microneedle 
patch was a mixture of PVA, dextran, and CMC. The polymer 
powders were slowly added to water in a wide-mouth bottle 
with magnetic stirring to form a 20% solution. After it was 
sealed with silver paper, the solution was heated to boiling and 
cooled to room temperature to form a hydrophilic polymer 
solution. Insulin was added to the solution directly, and then 
the mixture was stirred for 2 hours to make sure the drug was 
well dispersed. For sustained-release microneedles, the solu-
tion was cast in the female mold and pulled into microholes 
with the help of a vacuum on the opposite side. The mold with 
the polymer solution was frozen in a −20°C refrigerator for 
2 hours and then thawed at 4°C for 1 hour. This freeze-thaw 
cycle was repeated twice (three cycles in all) to cross-link and 
solidify the polymer. A piece of undried microneedle patch 
was prepared after detaching it from the female mold.
For fast-acting microneedles, a blank backing mem-
brane was prepared. PVA and dextran powders were mixed 
(98:2) and added into a round-bottom flask with water to 
form a 36% polymer solution. This solution was sealed and 
heated to boiling with power-driven simultaneous stirring. 
When cooled to about 60°C, the solution was poured onto 
a piece of quadrate glass board on the experimental table, 
followed by covering and pressing smoothly with another 
identical glass board to form the polymer membrane. 
The membrane’s thickness was controlled by adjusting the 
height of the supporters (1 mm was used in this study) at the 
four angles. After two freeze-thaw cycles, the membrane was 
cut into a circular shape to form a piece of blank backing 
layer. After casting and pulling the drug-loaded solution into 
the female mold, the backing layer was applied to the surface 
of the mold and pressed smooth. The next step was the same 
as for the sustained-release microneedles.
Drying
Both the free-drying step (step 1) and fixed-drying step 
(step 2) were carried out. In step 1, the microneedle patch 
was dried and shrunk to meet the size required. Subsequently, 
in step 2, the patch was fixed in a drying environment (low 
relative humidity and low pressure) to remove the remainder 
of the water. A special drying unit was prepared to carry 
out the drying process. A unit designed to dry one piece of 
patch was composed of three parts: bottom plate, a press 
board made of Teflon (press 1), and another press board 
made of stainless steel (press 2). Press 1 and press 2 were 
used to carry out step 1 and step 2, respectively (Figure 3). 
The bottom plate was made of a stainless-steel board with a 
round area removed and replaced by wire netting (Figure 3). 
The distance between the wire-netting surface and the plate’s 
upper surface was about 0.9 mm. Press 2 had the same shape 
as press 1, except for a welding ring (1.0 × 0.5 mm) used 
to fix the microneedle patch (Figure 3). Drying units can be 
integrated in a big plate, as in this study. We prepared each 
drying board with six drying units.
The undried microneedle patch was placed on the wire 
netting of a unit, with needles facing upward. After it was 
covered with press 1, the patch dried and contracted freely 
in still or flowing air. When it reached the desired size, the 
patch was fixed by press 2 and transferred into a vacuum-
drying oven for 12 hours. To investigate the effect of relative 
humidity and airflow rate in the drying process, microneedle 
patches were dried in environments with humidity of 50% 
AB CD
Purple sand mud
Figure 2 Fabrication of male mold of microneedles: (A) a single finished hexagonal steel stick; (B) thousands of steel sticks fixed into a steel bucket to form the core of the 
male mold; (C) the male mold with purple sand spreading smoothly; (D) the female mold prepared using the male mold.
submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
1417
Scalable fabrication of polymer microneedlesInternational Journal of Nanomedicine 2012:7
and 5% and airflow rates of 0 m/second and 1 m/second, 
respectively. The final microneedle product was gained by 
cutting the dried patch into a designated size.
Properties of the microneedles
Microneedle skin insertion
The hardness of the microneedles was determined by skin 
insertion. A piece of pigskin without subcutaneous fat 
was shaved and cleaned, and affixed under mild tension to 
a wooden plate. A microneedle patch with a diameter of 
12 mm was inserted by pressing against the backing layer 
with a thumb, using a force of approximately 1.5 N, and then 
removed immediately after the insertion. The microneedle 
insertion site on the skin surface was exposed for 10 minutes 
to trypan blue to dye the sites of stratum corneum perforation. 
After wiping residual dye from the skin surface with dry 
tissue paper, the skin and its tissue slice were viewed by 
microscopy (T1-SM; Nikon, Tokyo, Japan).
Swelling of the microneedles
The PVA microneedles have a property of swelling, which 
serves to open the diffusion channel for drug release when 
absorbing body fluid. To test the swelling of the microneedles, 
six blank patches were inserted into human arms and then 
covered with rigid tape (9860; 3M, St Paul, MN). The patches 
were detached from the skin and observed immediately at 
times of 1, 2, 3, 4, 5, and 6 hours.
In vitro release of insulin
The release kinetics of insulin from the fast-acting 
microneedle patches (n = 6) were examined by applying 
a patch to a piece of skin mounted in a Franz cell at 37°C. 
The microneedle patch was pressed onto the skin using the 
3M baking membrane. Insulin released into the receiving 
medium (pH 7.4 phosphate-buffered saline) in the Franz 
cell was determined using a Shimadzu (Kyoto, Japan) HPLC 
system equipped with a C-18 column (4.6 × 250 mm; Agilent 
Technologies, Santa Clara, CA). The receiving medium was 
replaced by a fresh medium and subjected to HPLC mea-
surement at 0.5, 1, 2, 3, 4, and 6 hours after release. Finally, 
the patch examined for release kinetics was cut into small 
pieces and suspended in the same releasing buffer at 37°C to 
collect the insulin remaining in the patch in order to assess 
the total insulin loading. The cumulative fractional release 
of insulin from the microneedle patches was calculated by 
dividing the measured amount at each sampling time by the 
total loaded insulin.
Results and discussion
Preparation of the female mold
The purple-sand mold’s breathability varied with different 
calcinating temperatures. As shown in Table 1, as the 
temperature increased, the mold became darker in color 
(Figure 4) and its breathability declined. The siphonage was 
serious with temperatures lower than 940°C (Table 1 and 
Figure 4A). The optimized temperature range for the female 
mold was 960°C–1000°C, in which the mold possessed good 
breathability and less siphonage.
The calcinating time was also important for properties of 
the female mold. Seven groups of adobes were calcinated in 
960°C for 1, 2, 3, 4, 6, 8, and 12 hours, respectively (Table 2). 
The ideal period for the female mold was 3–6 hours, and 
3 hours was commonly used to save time. As shown in 
Tables 1 and 2, the shrinkage of the mold (shrinkage-1) was 
also tested, which was useful in calculating the distribution 
of microneedles combined with the drying process.
Fabrication of the microneedle patches
An important step in the fabrication process was preparing the 
polymer solution. To reach the aim of obtaining a sufficient 
dosage encapsulated in the needles, insulin dispersed in 
the polymer solution was in a suspended form because 
Bottoming plate
Teflon
press board
Stainless steel
press board
Final patch
Fixed drying
Free drying
Figure 3 Drying process of microneedle patch. In the first step, the patch was dried 
with shrinking to adjust size and distance of needles. In the following step, the patch 
was completely dried with its size fixed.
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of the drug’s poor solubility. Each batch of microneedle 
patches was fabricated using a fresh drug-loaded polymer 
solution, each being stirred long enough to ensure uniform 
dispersion.
However, long stirring of the drug and the polymer solu-
tion produced many bubbles, which adversely affected the 
casting process and needle shape. A vacuum was used to try 
and eliminate the bubbles, but failed due to the high viscosity 
of the polymer solution. Moreover, a centrifugal method was 
also infeasible because of the drug deposition induced by 
centrifugal force. In our study, a spot of alcohol was added 
to the mixture, and this solved the problem. Alcohol was an 
ideal reagent due to its common use in insulin extraction. In 
addition, the alcohol had no effect on the microneedle patch 
because it was extracted completely in the drying process.
Drying
Drying boards designed for microneedle patches are shown 
in Figure 5. Six drying units were integrated in a steel plate 
with two protrusions to fix the press board. In the freeze-
drying step, shrinkage of the microneedle patch (shrinkage-2) 
was observed. In the static-air condition, the shrinking rate 
was negatively related to the relative humidity in the air 
(Figure 6A). Conversely, the drying rate accelerated with 
increased airflow rate (Figure 6B). Compared to relative 
humidity, the flowing air provided a better drying rate with 
light wind. However, the flowrate of the wind had to be 
controlled at a certain level since strong winds distorted the 
microneedle patch.
Shrinking the patches in the drying process provided an 
important advantage in controlling the needles’ intervals. The 
final intervals of the microneedles were calculated using the 
following formula: microneedle distance = needle distance 
of male mold × shrinkage-1 × shrinkage-2. Shrinkage-1 was 
constant when the calcinating parameters of purple sand were 
fixed. The difficulty level of preparing the male mold was 
decreased by the microneedle patch’s shrinking property. In 
brief, the flexible-sized hexagonal steel sticks used to form 
the male mold were selected, thereby reducing the   rejection 
rate and cost. Also, shrinking via drying maintained the 
needles’ shape. The microneedle patch dried using only step 2 
would produce needles with larger α-values because of water 
loss in the needle tip but a fixed size in the base. These short 
and blunt microneedles were ineffective in penetrating the 
skin’s epidermis.
Skin insertion
With the expectation that the microneedles should be suf-
ficiently hard, we inserted a piece of a microneedle patch 
with a diameter of 12 mm into pigskin and found that 
microneedles (0.8 mm in length and 0.3 mm in base) were 
embedded reliably into the skin using a force of about 
Table  1  Properties  of  purple-sand  female  mold  calcinated  at 
different temperatures (with calcinating time of 3 hours)
Temperature  
(°C)
920 940 960 980 1000 1020 1040
Colora + + ++ ++ ++ +++ +++
Breathabilityb +++ +++ ++ ++ + + +
Siphonagec +++ +++ ++ ++ ++ + +
Shrinkage-1 (%) 89.6 86.9 84.8 83.6 81.7 79.8 79.5
Notes: a+, yellow; +++, black. b+++, polymer solution can be pulled into microholes 
within 1 minute; ++, #5 minutes; +, .5 minutes.  c+++, hydrophilic and diffused; 
++, hydrophilic; +, hydrophobic.
AB C
Figure 4 Siphonage of female molds prepared at different temperatures: (A) 940°C; (B) 980°C; (C) 1020°C.
Table 2 Properties of purple-sand female mold calcinated with 
different times (at 960°C)
Time  
(hours)
1 2 3 4 6 8 12
Colora + + ++ ++ +++ +++ +++
Breathabilityb +++ +++ ++ ++ + + +
Siphonagec +++ +++ ++ ++ ++ + +
Shrinkage-1 (%) 86.8 85.5 84.8 84.1 82.3 80.9 80.6
Notes: a+, yellow; +++, black. b+++, polymer solution can be pulled into microholes 
within 1 minute; ++, #5 minutes; +, .5 minutes.  c+++, hydrophilic and diffused; 
++, hydrophilic; +, hydrophobic.
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AB C
Figure 5 Instruments used in microneedle-patch drying: (A) stainless plate with six drying units; (B) Teflon board (press 1) over the drying plate; (C) press 2 made of stainless 
steel with enough weight to fix microneedle patch.
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Figure 6 Shrinkage of microneedle patch in free-drying process: (A) effect of relative air humidity; (B) effect of airflow rate.
1 mm
AB
Figure 7 Skin penetration by microneedles: (A) pigskin dyed with trypan blue after microneedle patch removed; (B) micrograph of tissue slice of the pigskin.
AB
1 mm
C
Figure 8 Swelling of microneedles after inserting into human skin: (A) before patching; (B) 1 hour after patching; (C) 3 hours after patching.
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5 N with one thumb. After treating the skin with a dye 
that selectively marks sites of skin penetration, we found 
that all of the microneedles in the patch inserted into the 
skin (Figure 7A). A histological test of skin pierced with 
microneedles showed penetration depths of approximately 
0.4 mm (Figure 7B), which was about half of the length of 
a microneedle. This can be explained by the deformation 
of the skin’s surface known to occur during microneedle 
insertion due to the skin’s viscoelasticity.16 The relatively 
wide base (300 mm) and large α-value of the needle tip 
contributed to this incomplete insertion. Further optimization 
of the microneedle’s shape, such as α-value, shrinkage-2, 
and needle distance, may increase the insertion depth. In 
addition, formulation factors and the preparation process 
can also be considered to improve the needles’ strength. For 
example, increasing the dextran concentration in the polymer 
solution and freeze-thaw cycles were effective methods to 
strengthen microneedles. However, as discussed below, par-
tial microneedle insertion may be adequate for the swelling 
property presented in this study.
Swelling
Compared to other hydrophilic microneedles,8,11 the PVA 
microneedle would not dissolve in the skin, but swelling and 
therefore diffusion channels were opened for drug release.17 
A sustained type of microneedle patch was prepared to 
test swelling. The results are shown in Figure 8, in which 
the needles were adequately swollen after embedding into 
human skin. The weight of the microneedle patch varied from 
40 mg to about 55 mg, and the swelling could be adjusted by 
adding some polymer additives. Take CMC, for example: 
when absorbing fluid, CMC dissociated into long chains 
with a negative charge, which were mutually exclusive and 
produced a large space to hold water. Other polymers such 
as dextran and polyvinylpyrrolidone were diluents to cross-
linking points. The polymer additives were effective in for-
mulation to control the drug-release rate, both for sustained 
microneedles and fast-acting microneedles.
In vitro release of insulin
To examine the release kinetics of insulin from PVA 
microneedle patches, the dry patches were applied to por-
cine skin that was mounted on Franz cells filled with buffer 
solution. As shown in Figure 9, 30% of the total insulin 
load was released within the initial 30 minutes, followed 
by an additional 26% of the loaded cargo being released 
within 4 hours of patching. Although the kinetics of insulin 
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Figure 9 In vitro release profile of insulin from microneedle patches to Franz cells 
(n = 6).
release to a Franz cell may not necessarily be the same as the 
release kinetics to the dermis layer, the rapid insulin release 
(Figure 9) to human skin should be sufficient. The diffusion 
resistance from dermis to subcutaneous tissue may be a 
concern for practical usage of this insulin patch. However, 
both the force-assisted hollow microneedle patches and the 
body fluid-triggered soluble microneedle patches have been 
found to be capable of offering comparable insulin uptake to 
subcutaneous injections.2,11 The insulin-release rate shown 
in Figure 9 is comparable to those from the two microneedle 
patches above. The microneedle system could also improve 
through further formulation optimization.
Conclusion
The purple-sand female mold was prepared to fabricate a 
PVA microneedle patch in this study. This mold had the 
advantage of being breathable but water impermeable, 
and in coordination with a vacuum on the opposite side, it 
perfectly met the demand of hydrophilic microneedle patch 
preparation. Moreover, in the process of drying the cross-
linked microneedle patch, we developed instruments for 
free drying and shrinking, which controlled the needle 
distance and thereby simplified the preparation of the 
male mold.
We fabricated microneedles by the physical method 
of freeze–thawing them in a solidified polymer solution. 
This process was simple and safe compared with chemical 
cross-linking, in which a cross-linking agent is added.11,18 
An insulin-loaded microneedle patch was prepared and 
characterized in terms of hardness, swelling, and in vitro 
release. The pharmacokinetics and pharmacodynamics are 
now ongoing, and will be reported in future.
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